Ratios of THC metabolites in blood outperform standalone THC levels as markers of recent cannabis smoking, which could improve impairment testing.
Toxicologists, law enforcement, workplace safety professionals, policymakers, and cannabis consumers concerned about drug testing.
Ratios > THC aloneCannabinoid metabolite ratios in blood were superior to standalone THC as recent-use indicators
What the researchers found
Molar metabolite ratios of blood cannabinoids were superior to blood THC concentration alone as indicators of recent cannabis use, offering better discrimination between recent and non-recent consumption.
Why it matters
Current THC blood tests cannot reliably distinguish recent use from residual detection, creating problems for driving and workplace impairment assessment. Better biomarkers could make testing more fair and accurate.
The numbers in context
The observational study examined driving and psychomotor performance alongside blood cannabinoid measurements to compare metabolite ratios against standalone THC levels.
How the study worked
Observational study measuring blood cannabinoid levels alongside driving and psychomotor assessments to evaluate different biomarker approaches.
Who was studied
Cannabis users participating in controlled driving and psychomotor performance assessments.
What this study cannot tell us
Individual metabolism varies significantly; metabolite ratios may still not perfectly correlate with actual impairment levels across all users.
How to read the evidence
Observational study with direct biomarker measurements; moderate evidence supporting metabolite ratios over THC alone.
When this study was published
Recent research addressing an active policy and scientific debate.
The bigger picture
As cannabis legalization expands, the need for reliable recent-use biomarkers becomes critical for fair DUI and workplace drug testing policies that distinguish current impairment from past use.
Replication
Builds on prior pharmacokinetic research; metabolite ratio approach has growing support in toxicology literature.
Funding
Not specified
Conflicts of interest
Not specified
Questions still open
- Could metabolite ratios be standardized for roadside testing?
- How do chronic vs occasional users differ in metabolite ratio patterns?
- What ratio thresholds would best indicate potential impairment?
Read the original research
Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking.
Clinical toxicology (Philadelphia, Pa.), 61(5), 355-362
Citation
Kosnett, Michael J; Ma, Ming; Dooley, Gregory; Wang, George Sam; Friedman, Kyle; Brown, Timothy; Henthorn, Thomas K; Brooks-Russell, Ashley. (2023). Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking.. Clinical toxicology (Philadelphia, Pa.), 61(5), 355-362. https://doi.org/10.1080/15563650.2023.2214697